The Ozempic Effect
Oct 19, 2023•28 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
On the Money Café this week, Alan Kohler and Stephen Mayne discuss Stephen's board tilt for NAB, the latest AGM news, Ozempic, and answer a number of listener questions on short selling, housing, managed fund fees, and much more.
See omnystudio.com/listener for privacy information.
For the best experience, listen in Metacast app for iOS or Android